BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Eissa LA, Kenawy HI, El-Karef A, Elsherbiny NM, El-Mihi KA. Antioxidant and anti-inflammatory activities of berberine attenuate hepatic fibrosis induced by thioacetamide injection in rats. Chem Biol Interact. 2018;294:91-100. [PMID: 30138605 DOI: 10.1016/j.cbi.2018.08.016] [Cited by in Crossref: 25] [Cited by in F6Publishing: 35] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Abdo W, Haziri I, Dmerdash M, Alnasser SM, Hakamy A, Ali E, Soliman SA, Abd-Elhafeez HH, Abd-Eldayem AM. Anatabine attenuates ovalbumin-induced asthma via oxidative stress and inflammation mitigation and Nrf2/HO-1 signaling upregulation in rats. Life Sci 2022;308:120954. [PMID: 36103960 DOI: 10.1016/j.lfs.2022.120954] [Reference Citation Analysis]
2 Almatroodi SA, Alsahli MA, Rahmani AH. Berberine: An Important Emphasis on Its Anticancer Effects through Modulation of Various Cell Signaling Pathways. Molecules 2022;27:5889. [PMID: 36144625 DOI: 10.3390/molecules27185889] [Reference Citation Analysis]
3 Li W, Liu W, Qian D, Liu J, Zhou S, Zhang L, Peng W, Su L, Zhang H. Traditional Chinese medicine: An important source for discovering candidate agents against hepatic fibrosis. Front Pharmacol 2022;13:962525. [DOI: 10.3389/fphar.2022.962525] [Reference Citation Analysis]
4 Fu L, Mou J, Deng Y, Ren X. Structural modifications of berberine and their binding effects towards polymorphic deoxyribonucleic acid structures: A review. Front Pharmacol 2022;13:940282. [DOI: 10.3389/fphar.2022.940282] [Reference Citation Analysis]
5 El-mancy EM, Elsherbini DMA, Al-serwi RH, El-sherbiny M, Ahmed Shaker G, Abdel-moneim AH, Enan ET, Elsherbiny NM. α-Lipoic Acid Protects against Cyclosporine A-Induced Hepatic Toxicity in Rats: Effect on Oxidative Stress, Inflammation, and Apoptosis. Toxics 2022;10:442. [DOI: 10.3390/toxics10080442] [Reference Citation Analysis]
6 Alamery S, Zargar S, Yaseen F, Wani TA, Siyal A. Evaluation of the Effect of Wheat Germ Oil and Olmutinib on the Thioacetamide-Induced Liver and Kidney Toxicity in Mice. Life (Basel) 2022;12:900. [PMID: 35743930 DOI: 10.3390/life12060900] [Reference Citation Analysis]
7 Behl T, Singh S, Sharma N, Zahoor I, Albarrati A, Albratty M, Meraya AM, Najmi A, Bungau S. Expatiating the Pharmacological and Nanotechnological Aspects of the Alkaloidal Drug Berberine: Current and Future Trends. Molecules 2022;27:3705. [PMID: 35744831 DOI: 10.3390/molecules27123705] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Liu X, Wang L, Tan S, Chen Z, Wu B, Wu X. Therapeutic Effects of Berberine on Liver Fibrosis are associated With Lipid Metabolism and Intestinal Flora. Front Pharmacol 2022;13:814871. [PMID: 35308208 DOI: 10.3389/fphar.2022.814871] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 El-Fadaly AA, Afifi NA, El-Eraky W, Salama A, Abdelhameed MF, El-Rahman SSA, Ramadan A. Fisetin alleviates thioacetamide-induced hepatic fibrosis in rats by inhibiting Wnt/β-catenin signaling pathway. Immunopharmacol Immunotoxicol 2022;:1-12. [PMID: 35255766 DOI: 10.1080/08923973.2022.2047198] [Reference Citation Analysis]
10 Mohamed AA, Zaghloul RA, Abdelghany AM, El Gayar AM. Selenium nanoparticles and quercetin suppress thioacetamide-induced hepatocellular carcinoma in rats: Attenuation of inflammation involvement. J Biochem Mol Toxicol 2022;:e22989. [PMID: 35179263 DOI: 10.1002/jbt.22989] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Wang W, Gu W, He C, Zhang T, Shen Y, Pu Y. Bioactive components of Banxia Xiexin Decoction for the treatment of gastrointestinal diseases based on flavor-oriented analysis. J Ethnopharmacol 2022;:115085. [PMID: 35150814 DOI: 10.1016/j.jep.2022.115085] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Khan S, Hussain A, Attar F, Bloukh SH, Edis Z, Sharifi M, Balali E, Nemati F, Derakhshankhah H, Zeinabad HA, Nabi F, Khan RH, Hao X, Lin Y, Hua L, Ten Hagen TLM, Falahati M. A review of the berberine natural polysaccharide nanostructures as potential anticancer and antibacterial agents. Biomed Pharmacother 2021;146:112531. [PMID: 34906771 DOI: 10.1016/j.biopha.2021.112531] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Fernandes JC, Schemitt EG, Da Silva J, Marroni NP, Lima A, Ferreira RB. Combination of Trans-Resveratrol and ε-Viniferin Induces a Hepatoprotective Effect in Rats with Severe Acute Liver Failure via Reduction of Oxidative Stress and MMP-9 Expression. Nutrients 2021;13:3677. [PMID: 34835933 DOI: 10.3390/nu13113677] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Zhang D, Zhang L, Chen G, Xu Y, Yang H, Xiao Z, Chen J, Mu Y, Zhang H, Liu W, Liu P. Hepatoprotective effect of Xiayuxue decoction ethyl acetate fraction against carbon tetrachloride-induced liver fibrosis in mice via inducing apoptosis and suppressing activation of hepatic stellate cells. Pharm Biol 2020;58:1229-43. [PMID: 33332219 DOI: 10.1080/13880209.2020.1855212] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
15 Verma VK, Malik S, Mutneja E, Sahu AK, Rupashi K, Dinda AK, Arya DS, Bhatia J. Mechanism Involved in Fortification by Berberine in CDDP-Induced Nephrotoxicity. Curr Mol Pharmacol 2020;13:342-52. [PMID: 32077836 DOI: 10.2174/1874467213666200220142202] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
16 Ahrari A, Najafzadehvarzi H, Taravati A, Tohidi F. The inhibitory effect of PLGA-encapsulated berberine on hepatotoxicity and α-smooth muscle actin (α-SMA) gene expression. Life Sci 2021;284:119884. [PMID: 34389401 DOI: 10.1016/j.lfs.2021.119884] [Reference Citation Analysis]
17 Ibrahim Fouad G, Ahmed KA. The protective impact of berberine against doxorubicin-induced nephrotoxicity in rats. Tissue Cell 2021;73:101612. [PMID: 34371291 DOI: 10.1016/j.tice.2021.101612] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
18 Shalkami AS, Hassanein EHM, Sayed AM, Mohamed WR, Khalaf MM, Hemeida RAM. Hepatoprotective effects of phytochemicals berberine and umbelliferone against methotrexate-induced hepatic intoxication: experimental studies and in silico evidence. Environ Sci Pollut Res Int 2021;28:67593-607. [PMID: 34258700 DOI: 10.1007/s11356-021-15358-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
19 Seen S. Chronic liver disease and oxidative stress - a narrative review. Expert Rev Gastroenterol Hepatol 2021;15:1021-35. [PMID: 34176419 DOI: 10.1080/17474124.2021.1949289] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
20 Bansod S, Saifi MA, Godugu C. Molecular updates on berberine in liver diseases: Bench to bedside. Phytother Res 2021. [PMID: 34056769 DOI: 10.1002/ptr.7181] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
21 DiNicolantonio JJ, McCarty MF, Barroso-Aranda J, Assanga S, Lujan LML, O'Keefe JH. A nutraceutical strategy for downregulating TGFβ signalling: prospects for prevention of fibrotic disorders, including post-COVID-19 pulmonary fibrosis. Open Heart 2021;8:e001663. [PMID: 33879509 DOI: 10.1136/openhrt-2021-001663] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Tong Y, Liu L, Wang R, Yang T, Wen J, Wei S, Jing M, Zou W, Zhao Y. Berberine Attenuates Chronic Atrophic Gastritis Induced by MNNG and Its Potential Mechanism. Front Pharmacol 2021;12:644638. [PMID: 33841162 DOI: 10.3389/fphar.2021.644638] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
23 Wang Y, Wang S, Wang R, Li S, Yuan Y. Neferine Exerts Antioxidant and Anti-Inflammatory Effects on Carbon Tetrachloride-Induced Liver Fibrosis by Inhibiting the MAPK and NF-κB/IκBα Pathways. Evid Based Complement Alternat Med 2021;2021:4136019. [PMID: 33680053 DOI: 10.1155/2021/4136019] [Reference Citation Analysis]
24 Zhang L, Wu X, Yang R, Chen F, Liao Y, Zhu Z, Wu Z, Sun X, Wang L. Effects of Berberine on the Gastrointestinal Microbiota. Front Cell Infect Microbiol 2020;10:588517. [PMID: 33680978 DOI: 10.3389/fcimb.2020.588517] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
25 Wang T, Zhou X, Kuang G, Jiang R, Guo X, Wu S, Wan J, Yin L. Paeoniflorin modulates oxidative stress, inflammation and hepatic stellate cells activation to alleviate CCl4-induced hepatic fibrosis by upregulation of heme oxygenase-1 in mice. J Pharm Pharmacol 2021;73:338-46. [PMID: 33793876 DOI: 10.1093/jpp/rgaa042] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Zhou M, Deng Y, Liu M, Liao L, Dai X, Guo C, Zhao X, He L, Peng C, Li Y. The pharmacological activity of berberine, a review for liver protection. Eur J Pharmacol 2021;890:173655. [PMID: 33068590 DOI: 10.1016/j.ejphar.2020.173655] [Cited by in F6Publishing: 17] [Reference Citation Analysis]
27 Ma X, Jiang Y, Wen J, Zhao Y, Zeng J, Guo Y. A comprehensive review of natural products to fight liver fibrosis: Alkaloids, terpenoids, glycosides, coumarins and other compounds. Eur J Pharmacol 2020;888:173578. [PMID: 32976828 DOI: 10.1016/j.ejphar.2020.173578] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
28 Elnfarawy AA, Nashy AE, Abozaid AM, Komber IF, Elweshahy RH, Abdelrahman RS. Vinpocetine attenuates thioacetamide-induced liver fibrosis in rats. Hum Exp Toxicol 2021;40:355-68. [DOI: 10.1177/0960327120947453] [Cited by in Crossref: 2] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
29 Ruiz Castro PA, Kogel U, Lo Sasso G, Phillips BW, Sewer A, Titz B, Garcia L, Kondylis A, Guedj E, Peric D, Bornand D, Dulize R, Merg C, Corciulo M, Ivanov NV, Peitsch MC, Hoeng J. Anatabine ameliorates intestinal inflammation and reduces the production of pro-inflammatory factors in a dextran sulfate sodium mouse model of colitis. J Inflamm (Lond) 2020;17:29. [PMID: 32855621 DOI: 10.1186/s12950-020-00260-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
30 Samadi P, Sarvarian P, Gholipour E, Asenjan KS, Aghebati-Maleki L, Motavalli R, Hojjat-Farsangi M, Yousefi M. Berberine: A novel therapeutic strategy for cancer. IUBMB Life 2020;72:2065-79. [PMID: 32735398 DOI: 10.1002/iub.2350] [Cited by in Crossref: 4] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
31 Pierpaoli E, Cirioni O, Simonetti O, Orlando F, Giacometti A, Lombardi P, Provinciali M. Potential application of berberine in the treatment of Escherichia coli sepsis. Nat Prod Res 2020;:1-6. [PMID: 32011175 DOI: 10.1080/14786419.2020.1721729] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
32 Wang Y, Liu Y, Du X, Ma H, Yao J. The Anti-Cancer Mechanisms of Berberine: A Review. Cancer Manag Res 2020;12:695-702. [PMID: 32099466 DOI: 10.2147/CMAR.S242329] [Cited by in Crossref: 18] [Cited by in F6Publishing: 47] [Article Influence: 9.0] [Reference Citation Analysis]
33 Wang Z, Wang J, Chen H, Tang J, Bian A, Liu T, Yu L, Yi Z, Yang F. Synthesis and anticancer activity of novel 9,13-disubstituted berberine derivatives. Bioorganic & Medicinal Chemistry Letters 2020;30:126821. [DOI: 10.1016/j.bmcl.2019.126821] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
34 Wang C, Wang Y, Ma SR, Zuo ZY, Wu YB, Kong WJ, Wang AP, Jiang JD. Berberine inhibits adipocyte differentiation, proliferation and adiposity through down-regulating galectin-3. Sci Rep 2019;9:13415. [PMID: 31527742 DOI: 10.1038/s41598-019-50103-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
35 Schemitt EG, Hartmann RM, Colares JR, Licks F, Salvi JO, Marroni CA, Marroni NP. Protective action of glutamine in rats with severe acute liver failure. World J Hepatol 2019; 11(3): 273-286 [PMID: 30967905 DOI: 10.4254/wjh.v11.i3.273] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
36 Casas-Grajales S, Reyes-Gordillo K, Cerda-García-Rojas CM, Tsutsumi V, Lakshman MR, Muriel P. Rebaudioside A administration prevents experimental liver fibrosis: an in vivo and in vitro study of the mechanisms of action involved. J Appl Toxicol 2019;39:1118-31. [PMID: 30883860 DOI: 10.1002/jat.3797] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
37 Su G, Li Z, Wang R, Lu Y, Nan J, Wu Y, Zhao Y. Signaling pathways involved in p38-ERK and inflammatory factors mediated the anti-fibrosis effect of AD-2 on thioacetamide-induced liver injury in mice. Food Funct 2019;10:3992-4000. [DOI: 10.1039/c8fo02405g] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]